Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Parenteral and Enteral Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Moore, R. A.
Right arrow Articles by Dudrick, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, R. A.
Right arrow Articles by Dudrick, S. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CIMETIDINE
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Cimetidine and Parenteral Nutrition

Richard A. Moore, PHARM.D.

Department of Clinical Pharmacy and Administration, University of Houston College of Pharmacy, Texas Medical Center, Houston, Texas

Stuart Feldman, PH.D.

Department of Pharmaceutics, University of Houston College of Pharmacy, Texas Medical Center, Houston, Texas

John Treuting, PH.D.

University of Texas Medical School at Houston, Hermann Hospital, Houston, Texas

Robert Bloss, M.D.

University of Texas Medical School at Houston, Hermann Hospital, Houston, Texas

Stanley J. Dudrick, M.D.

University of Texas Medical School at Houston, Hermann Hospital, Houston, Texas

A number of patients receiving continuous intravenous infusions of hyperalimentation solutions require cimetidine (CT) for treatment of gastric hypersecretory conditions. Four patients were selected to receive a CT-hyperalimentation mixture and serial blood sampling for CT concentrations. Rates of infusion of CT ranged from 38 to 56.3 mg/hr. Average serum concentrations (C ss) of CT at steady state ranged from 0.6 to 1.0 µg/ml. This concentration range is near levels reported in patients receiving long-term oral CT and is lower than levels reported to be associated with central nervous system toxicity. No evidence of renal toxicity was noted. Pharmacokinetic parameters were comparable to previous reports in the literature. This initial investigation reveals that continuous intravenous infusion of CT in hyperalimentation solutions appears to be a safe mode of drug administration. More definitive studies are needed to assess efficacy.

Journal of Parenteral and Enteral Nutrition, Vol. 5, No. 1, 61-63 (1981)
DOI: 10.1177/014860718100500161


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Nutr Clin PractHome page
D. F. Driscoll, B. R. Bistrian, R. J. Baptista, S. Randall, and G. L. Blackburn
Base Solution Limitations and Patient-Specific TPN Admixtures
Nutr Clin Pract, August 1, 1987; 2(4): 160 - 163.
[PDF]